Buy, US$670.00 target, 65.4 per cent upside, per institutional sell-side research. AI equipment demand and higher margin targets drive Applied Materials.
Buy rated by institutional sell-side research with a US$32.00 target, 148.6 per cent upside, ahead of Phase 3 wet AMD gene therapy data in 2Q27.
Buy-rated On Holding (ONON); US$44 target, 45.7% upside. Q2’26 adj. EBITDA margin 19.8%, gross margin 65.4%, before any tariff refund.
Tradeweb Markets (NASDAQ: TW) US$119.82 ▲ +0.13% at US$98.83 on ~22x forward earnings, near its own multi-year low. Rates growth and electronic runway intact. Buy, ~47% upside.
BuyInteractive Brokers is a global electronic broker that runs a low-cost trading platform for active retail investors and small to mid-size...
BuyWalmart is the world's largest retailer by revenue, running about 10,600 stores and clubs across 19 countries under the Walmart, Sam's...
MongoDB (MDB US$393.44 ▲ +0.92%) is rated a Buy with a US$360 price target, implying 8 per cent upside. The thesis rests on Atlas cloud consumption growth, an AI-native product strategy, and an earnings trajectory that compresses the P/E from 55x to 36x by FY29.
BuyUpwork runs the world's largest online work marketplace, connecting businesses with independent professionals in software development,...
LLY Buy with ~37% upside to ~US$1,283. 1Q26 EPS US$8.55 beat US$6.77, 2026 guide raised to US$82-85bn. Foundayo oral GLP-1 hits 8k prescribers in 3 weeks, 80% new incretin patients.
HoldTesla makes electric vehicles and battery energy storage products, and is building solar, artificial intelligence and robotics...
MF & Co. Asset Management is a boutique investment firm offering Equity Capital Markets and derivative general advice & trade execution services.
We are specialists in advising and trading in Australian and US Equities, Index & Equity Options and Options on Futures.
Australia
1300 889 603
International
+61 2 8378 7199
M-F: 8am-5pm
Suite 803, Level 8
70 Pitt St, Sydney, NSW 2000